Stock Today: Netflix Hits One-Year Low, Dow, S&P 500 & Nasdaq Futures Climb, GE Aerospace Strong, Greenwich LifeSciences Surges

3 Key Points:

• Netflix shares fall to a one-year low amid rising costs and slower revenue growth.

• Dow, S&P 500, and Nasdaq futures climb after easing of trade tensions.

• GE Aerospace beats earnings estimates, while Greenwich LifeSciences surges 54% following FDA approval of GP2.

advertisement

Introduction:

Today’s stock market headlines reflect a mix of challenges, optimism, and breakthroughs across sectors. Netflix faces a one-year low following disappointing earnings and rising costs, while US futures for the Dow, S&P 500, and Nasdaq climb amid easing trade tensions. Industrial giant GE Aerospace impresses investors with strong earnings that beat expectations, and biopharmaceutical company Greenwich LifeSciences soars after FDA approval of its GP2 product for Phase III clinical trials. Here’s a detailed look at the key movers shaping the market on Thursday, January 22, 2026.

Netflix: FANG-Era Star Hits a One-Year Low

Netflix (NASDAQ: NFLX) shares are at their lowest point in a year following a disappointing earnings report. Analysts attribute the decline to high expectations, costly acquisitions, and Netflix’s absence from the AI-driven rally that benefits other tech giants.

Key challenges highlighted in the latest earnings include:

• Rising costs: Netflix’s pending acquisition of Warner Bros. Discovery is expected to increase expenses, alongside a 10% boost in spending on TV shows and films.

• Slowing revenue growth: Forecasts for 2026 predict 13% revenue growth, down from 16% in 2025, with expansion into live sports adding further cost pressures.

• Free cash flow miss: Analysts anticipated higher free cash flow than the reported $11 billion, adding to investor concern.

Despite this, sentiment among analysts remains largely positive. 65% recommend a “buy,” citing the undervalued stock price and the potential growth of Netflix’s $3 billion advertising business.

advertisement

US Futures: Dow, S&P 500, Nasdaq Rise on Trade Relief

US stock futures climbed Thursday following news that President Trump paused proposed 10% tariffs on European allies over Greenland. This easing of geopolitical tensions helped lift investor confidence:

• Nasdaq 100 futures rose 0.8%

• S&P 500 futures increased 0.6%

• Dow Jones Industrial Average futures gained 0.3%

Tech stocks led the gains, with investors also monitoring earnings reports from Intel, Meta, Procter & Gamble, and GE Aerospace. Economic indicators such as the PCE price index, weekly jobless claims, and third-quarter GDP updates are also expected to guide market sentiment in the coming days.

Greenwich LifeSciences: Biopharma Breakthrough

Greenwich LifeSciences (NASDAQ: GLSI) saw its stock surge 54% after FDA approval of its first commercial GP2 lot for the FLAMINGO-01 Phase III trial. The trial evaluates GLSI-100, an immunotherapy aimed at preventing breast cancer recurrences.

Key points include:

• First commercial GP2 lots were manufactured in 2023 with the potential for ~200,000 doses.

• GP2 vials will soon be used across 40 U.S. trial sites.

• Preliminary data suggests an ~80% reduction in breast cancer recurrence, aligning with prior Phase IIb results.

• The company plans to submit manufacturing data to regulators in Europe, the UK, and Canada in preparation for a potential product launch.

advertisement

GE Aerospace: Earnings Beat Expectations

Separately, GE Aerospace (NYSE: GE) reported Q4 EPS of $1.57, beating analyst estimates of $1.43. Revenue reached $11.87 billion, surpassing the $11.2 billion forecast. Guidance for FY 2026 predicts EPS of $7.10–$7.40, closely aligned with the consensus of $7.12. The stock closed at $318.50, reflecting solid performance over the past year.

Conclusion:

Today’s market highlights the diversity of investor opportunities. While Netflix faces challenges and a one-year low, growth-oriented investors may find value in its advertising business. US futures indicate cautious optimism amid easing trade tensions, while biopharma innovators like Greenwich LifeSciences demonstrate how FDA approvals can drive dramatic stock surges. Meanwhile, established industrial giants like GE Aerospace continue to deliver strong earnings and consistent growth. These developments underscore the importance of balanced portfolios and awareness of both short-term catalysts and long-term fundamentals.

Key Points Summary:

• Netflix stock hits one-year low amid rising costs and slowing revenue.

• Dow, S&P 500, Nasdaq futures rise after trade tension eases.

• Greenwich LifeSciences jumps 54% on FDA approval of GP2 for clinical trial.

• GE Aerospace beats earnings and maintains strong guidance for 2026.

advertisement

Frequently Asked Questions (FAQ):

1. Why is Netflix stock falling?
   Netflix is dealing with high costs from acquisitions, slowing revenue growth, and missing free cash flow targets, despite positive analyst sentiment.

2. What caused US stock futures to rise?
   Futures rose as President Trump paused threatened tariffs on European allies, easing trade and geopolitical concerns.

3. Why did Greenwich LifeSciences stock surge?
   The FDA approved the use of its commercial GP2 lot in the FLAMINGO-01 Phase III trial, boosting investor confidence.

4. How did GE Aerospace perform in its latest earnings report?
   GE Aerospace reported Q4 EPS of $1.57 and revenue of $11.87B, both above estimates, and provided FY 2026 guidance aligned with analyst expectations.

5. Should investors buy Netflix or Greenwich LifeSciences now?
   Analysts remain bullish on Netflix’s long-term prospects despite short-term challenges, while Greenwich LifeSciences’ FDA approval presents potential growth, though it carries clinical trial risk.

Sources:

• Yahoo Finance – Netflix shares hit one-year low after earnings miss
  https://finance.yahoo.com/news/netflixs-stock-lost-fang-era-104001198.html

• Yahoo Finance – Dow, S&P 500, Nasdaq futures rise after Trump backpedals on tariffs
  https://finance.yahoo.com/news/live/stock-market-today-dow-sp-500-nasdaq-futures-rise-after-trump-backpedals-on-tariffs-234947394.html

• Investing.com – GE Aerospace earnings beat by $0.14, revenue topped estimates
  https://www.investing.com/news/earnings/ge-aerospace-earnings-beat-by-014-revenue-topped-estimates-4459836

• Investing.com – Greenwich LifeSciences stock soars after FDA approves commercial GP2 in trial
  https://www.investing.com/news/stock-market-news/greenwich-lifesciences-stock-soars-after-fda-approves-commercial-gp2-in-trial-93CH-4459982

Thank you !